A systematic review of nicardipine hydrochloride

A common dihydropyridine calcium channel blocker with proven effectiveness in the treatment of a
number of cardiovascular diseases is nicardipine hydrochloride. The goal of this systematic review is to
thoroughly assess and compile the body of knowledge regarding nicardipine hydrochloride, including its
safety profile, clinical indications, pharmacological characteristics, and developing research directions.
After a thorough search of electronic databases, a wide variety of papers, including meta-analyses,
observational studies, and randomized controlled trials, were found. A thorough analysis is conducted of
the pharmacological properties of nicardipine hydrochloride, encompassing its mechanism of action,
pharmacokinetics, and interactions. A comprehensive study of nicardipine hydrochloride's clinical uses in
the treatment of hypertension, angina pectoris and subarachnoid hemorrhage provides insight into the
drug's effectiveness and relative efficacy. A complete analysis of safety factors, including as side effects
and contraindications, is conducted to offer a comprehensive understanding of the risk-benefit profile
related to the usage of nicardipine hydrochloride.